. 2022 Dec 2;101(48):e32057. doi: 10.1097/MD.0000000000032057

Table 7.

TC, TG, LDL-C, FBG, FINS, HOMA-IRI, TNF-α, IL-6, IL-1, levels of the 2 groups.

Item	Experimental group		Control group
Item	Baseline	Posttreatment	Baseline	Posttreatment
FBG (mmol·L⁻¹)	5.81 ± 0.67	4.97 ± 0.43^*^#	5.78 ± 0.64	5.34 ± 0.48^*
FINS (mU·L⁻¹)	12.69 ± 2.34	8.34 ± 1.67^*^#	12.14 ± 2.21	10.05 ± 1.73^*
HOMA-IRI	3.27 ± 0.51	1.85 ± 0.33^*^#	3.12 ± 0.47	2.37 ± 0.40^*
TC (mmol·L⁻¹)	5.28 ± 0.78	4.23 ± 0.54^*^#	5.16 ± 0.87	4.63 ± 0.54^*
TG (mmol·L⁻¹)	2.41 ± 0.81	1.66 ± 0.52^*^#	2.55 ± 0.54	2.01 ± 0.66^*
LDL-C (mmol·L⁻¹)	3.78 ± 0.31	3.22 ± 0.28^*^#	3.75 ± 0.33	3.32 ± 0.29^*
TNF-α (ng·L⁻¹)	32.78 ± 4.43	17.29 ± 2.38^*^#	33.16 ± 4.57	20.58 ± 2.69^*
IL-6 (ng·L⁻¹)	31.07 ± 4.36	17.53 ± 2.19^*^#	30.95 ± 4.47	21.19 ± 2.82^*
IL-1 (ng·L⁻¹)	28.12 ± 4.24	15.36 ± 2.25^*^#	27.74 ± 4.13	18.27 ± 2.50^*

FBG = fasting blood glucose, FINS = fasting insulin, HOMA-IRI = homeostasis model assessment of insulin resistance index, IL-6 = interleukin-6, IL-1 = interleukin 1, LDL-C = low-density lipoprotein cholesterol, TC = total cholesterol, TG = triglycerides, TNF-α = tumor necrosis factor-alpha.

P < .01, compared with baseline.

#P < .01, compared with the control group after treatment.